Follow the CITIUS ONCOLOGY, INC. stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €68.6m. The latest transaction was disclosed on 22 December 2025 (Attribution). Among the most active insiders: HOLUBIAK MYRON Z. Every trade is free.
32
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate CITIUS ONCOLOGY, INC. Buy (bullish), based on 1 analysts. Average price target: US$4.00.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
CITIUS ONCOLOGY, INC. is a company focused on developing innovative cancer treatments. It aims to improve outcomes for patients with oncological diseases.